|
Catalog Number 07.702.016S |
Device Problem
Fluid/Blood Leak (1250)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/06/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: d9: complainant part is not expected to be returned for manufacturer review/investigation.E3: reporter is a j&j employee.H3, h6: the investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Event Description
|
Device report from synthes reports an event in japan as follows: it was reported that this was a percutaneous vertebroplasty (vertebral body stenting) and posterior fusion (th11-l1) using fenestrated screw for osteoporosis case vertebral fracture (th12) on (b)(6)2023.This was a report about the intravascular leakage of the bone cement.In the surgery, the surgeon inserted a verse fnestrated screw 6 x 45 mm into th11 left.The screw was proper position, and the transverse hole was confirmed to be in the proper position anteriorly from the center of the vertebral body.After 8 minutes and 30 seconds from the start of the cement agitation, the viscosity was appropriate and cement injection into the screw was started.The image showed cement spreading around the screw from about 0.4¿.After 0.7¿ of cement had been placed, a single line of shading was seen near the center of the vertebral body in the lateral image.It could not be confirmed in the frontal image as it seemed to be in a position that covered the device.Since it was suspected that the cement had entered a blood vessel, cement injection was terminated at that point.The surgery was completed successfully within 30 minutes surgical delay.Patient status/ outcome: stable immediate postoperative ct imaging revealed cementation in a vessel that appeared to be a segmental vein along the left lateral wall of th11.Since the dose was small and the patient did not show any particular abnormality, it was determined to be asymptomatic and unproblematic.No further information is available.*remarks: this (b)(4) and (b)(4) are involved with the same event.(b)(4) (depuy spine): screw (b)(4) (synthes spine): cement this report is for one (1) vertecem v+ cement kit this is report 1 of 1 for complaint (b)(4).
|
|
Manufacturer Narrative
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device history review (dhr): part: 07.702.016s, lot: 3b53590, release to warehouse date: 03 feb 2023, manufacturing site: werk selzach, expiration date: 01 feb 2026 , supplier: (b)(4).A manufacturing record evaluation was performed for the finished article lot and no non-conformances were identified.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Search Alerts/Recalls
|
|
|